GSS
GENETIC SIGNATURES LIMITED
$0.0800
▲ +1.27%
Market cap
$18M
Turnover
$2,009
Last price
$0.0800
Day change
+1.27%
Announcements
12
Range, past year
Open 0.230 · Low 0.051 · Now 0.080 · High 0.690
Open GSS in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
GSS momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
39/100
Wyckoff phase
Accumulation45d
Trend stage
Emerging
1 Day
+1.3%
1 Week
+1.3%
1 Month
-1.2%
1 Year
-62.8%
RSI
53
Avg daily range
5.8%
GENETIC SIGNATURES LIMITED scores 39 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Emerging.
On the Wyckoff cycle it sits in Accumulation, where it has been for 45 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently outperforming and the institutional accumulation signal reads low.
What stands out
- Fresh trend age (18 days)
Points to watch
- 60d drawdown -28.4%
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
GSS announcements
Recent price-sensitive releases.
- 2026-10-08 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - First Quarter Activity Report | Commitments Test Entity - First Quarter Cashflow Report
- 2026-09-22 GSS Investor Presentation - Proposed Merger with MAP Company Presentation
- 2026-09-22 GSS and MAP agree to Commercial Terms for Merger Scheme of Arrangement | Takeover - Timer Applied
- 2026-09-17 Receipt of Section 249D Notice from BCAL Diagnostics Notice of Meeting - Other
- 2026-09-03 BDX Holdings of GSS Shares and receipt of Section 249D Security holder details - Other | Notice of Meeting - Other
- 2026-08-26 Genetic Signatures and Microba in Merger Discussions Progress Report
- 2026-08-25 FY26 Market Update Company Presentation | Preliminary Final Report
More Health Care stocks
Most traded in the same sector.